{"filing":{"accession_number":"0001213900-26-071390","cik":"0001946399","ticker":"LSBWF","company_name":"LakeShore Biopharma Co., Ltd.","form":"6-K","filing_date":"2026-06-24","report_date":null,"primary_document":"ea0295625-6k_lakeshore.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1946399/000121390026071390/ea0295625-6k_lakeshore.htm"},"events":[{"id":13438,"run_id":11937,"accession_number":"0001213900-26-071390","anchor_item_number":"EX-99.1","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"This press release announces the completion of a merger transaction in which LakeShore Biopharma became a wholly owned subsidiary of Oceanpine Skyline Inc. pursuant to an Agreement and Plan of Merger dated November 4, 2025. The merger resulted in the cancellation of all ordinary shares in exchange for US$0.066 per share in cash, and the Company will cease to be publicly traded. This is a material change of control and completion of a merger transaction, directly falling under ma_activity (Items 1.01, 2.01).","company_name":"LakeShore Biopharma Co., Ltd.","ticker":"LSBWF","filing_date":"2026-06-24","form":"6-K","submitted_at":null,"items":[{"id":10579,"accession_number":"0001213900-26-071390","item_number":"EX-99.1","item_title":"ea029562501ex99-1.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This press release announces the completion of a merger transaction in which LakeShore Biopharma became a wholly owned subsidiary of Oceanpine Skyline Inc. pursuant to an Agreement and Plan of Merger dated November 4, 2025. The merger resulted in the cancellation of all ordinary shares in exchange for US$0.066 per share in cash, and the Company will cease to be publicly traded. This is a material change of control and completion of a merger transaction, directly falling under ma_activity (Items 1.01, 2.01).","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-24T16:16:37.504567+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10579,"accession_number":"0001213900-26-071390","item_number":"EX-99.1","item_title":"ea029562501ex99-1.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This press release announces the completion of a merger transaction in which LakeShore Biopharma became a wholly owned subsidiary of Oceanpine Skyline Inc. pursuant to an Agreement and Plan of Merger dated November 4, 2025. The merger resulted in the cancellation of all ordinary shares in exchange for US$0.066 per share in cash, and the Company will cease to be publicly traded. This is a material change of control and completion of a merger transaction, directly falling under ma_activity (Items 1.01, 2.01).","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-24T16:16:37.504567+00:00","company_name":"LakeShore Biopharma Co., Ltd.","ticker":"LSBWF","filing_date":"2026-06-24"}]}